Physician profile
Mark A Schusterman
NPI 1366872020
$27,780.42
in general payments reported to CMS, 2019-2025
26 companies · $24K in 2025
The $24K reported for 2025 was more than what 97% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2021: $265 · 2022: $1,846 · 2023: $613 · 2024: $853 · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $23K · Food and Beverage: $2,550 · Travel and Lodging: $22.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $22,953.61 |
| Food and Beverage | $2,549.79 |
| Travel and Lodging | $22.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Health Care Systems INC. | $22,953.61 | 2025 | |
| Tela Bio, INC. | $1,766.30 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Abbvie INC. | $625.77 | 2023-2025 | Alloderm, Natrelle Saline-Filled Breast Implants |
| Allergan, INC. | $391.98 | 2019-2022 | |
| Integra Lifesciences Corporation | $270.47 | 2022-2025 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Davol INC. | $259.22 | 2019-2024 | Phasix Mesh |
| Kerecis Limited | $198.78 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Revance Therapeutics, INC. | $178.30 | 2024 | Daxxify |
| Axogen | $176.37 | 2022-2025 | Avance Nerve Graft, Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector |
| Sientra, INC. | $163.47 | 2022 | |
| Stryker Corporation | $135.79 | 2021-2024 | Spy-Phi System |
| Avita Medical Americas, LLC | $114.32 | 2025 | Cohealyx, Recell, Permeaderm |
| Musculoskeletal Transplant Foundation INC. | $101.77 | 2021-2024 | |
| Rti Surgical, INC | $74.03 | 2025 | |
| Elucent Medical | $55.94 | 2024 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $46.89 | 2024-2025 | Restrata Wound Matrix |
| Medical Device Business Services, INC. | $38.21 | 2022-2023 | Vistaseal |
| Kci USA, INC. | $37.90 | 2022 | |
| Medtronic, INC. | $34.37 | 2025 | Ligasure |
| Smith+Nephew, INC. | $33.47 | 2025 | Grafix Pl |
| Lifenet Health | $30.58 | 2025 | Theragenesis Wound Matrix |
| W. L. Gore & Associates, INC. | $21.46 | 2025 | Gore Enform Preperitoneal Biomaterial |
| Pacira Pharmaceuticals Incorporated | $20.15 | 2021 | |
| Solventum Corporation | $19.71 | 2024 | Activ.A.C., Prevena, V.A.C. Dermatac |
| Baxter Healthcare | $16.20 | 2024 | Perclot |
| Coopersurgical, INC. | $15.36 | 2024 | Insorb |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Schusterman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.